Sumitomo Dainippon Pharma Co Ltd's Fiscal Year is From April To March.
The item "Working-Capital-Turnover" stands at 141.73 as of 09/30/2025, the highest value at least since 06/30/2022, the period currently displayed.
As of the end of Sumitomo Dainippon Pharma Co Ltd's second quarter, the item "Working Capital Turnover" stands at 141.73. This represents an increase of 1,479.48 percent compared to it's value at the end of it's first quarter .
Regarding the One-Year-Change of the series, the current value constitutes an increase of 144.10 compared to the value the year prior.
The Serie's long term average value is 8.85. It's latest available value, on 09/30/2025, is 132.88 higher, compared to it's long term average value.
The Serie's change from it's minimum value, on 06/30/2025, to it's latest available value, on 09/30/2025, is +152.00 .
The Serie's change from it's maximum value, on 09/30/2025, to it's latest available value, on 09/30/2025, is 0.0 .
| Logo | Name | Market Cap (USD) |
|---|---|---|
![]() | Eli Lilly and Company - Working Capital Turnover | 905,699,262,464.00 |
![]() | Johnson & Johnson - Working Capital Turnover | 486,508,953,600.00 |
![]() | AbbVie Inc - Working Capital Turnover | 399,570,305,024.00 |
![]() | Roche Holding AG - Working Capital Turnover | 317,433,206,677.55 |
![]() | AstraZeneca PLC - Working Capital Turnover | 280,205,508,085.11 |